Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 22 | $25,027,879 |
Sells | 111 | $99,885,269 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 03 Nov 2022 | Sale | 21,085 | 30 | 632,550 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 03 Nov 2022 | Sale | 75,312 | 30 | 2,259,360 | D |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 02 Nov 2022 | Sale | 27,038 | 30.02 | 811,681 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 1,044 | 31.08 | 32,448 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 3,727 | 31.08 | 115,835 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 15,804 | 30.57 | 483,128 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 31 Oct 2022 | Sale | 26,383 | 30.23 | 797,558 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 28 Oct 2022 | Sale | 19,915 | 30 | 597,450 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 1,044 | 31.08 | 32,448 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 3,727 | 31.08 | 115,835 | D |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 15,804 | 30.57 | 483,128 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | D |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 31 Oct 2022 | Sale | 26,383 | 30.23 | 797,558 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | D |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 28 Oct 2022 | Sale | 19,915 | 30 | 597,450 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 27,117 | 26 | 705,042 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 233,362 | 26 | 6,067,412 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 285,046 | 26 | 7,411,196 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 27 May 2022 | Purchase | 3,223 | 14.7828 | 47,645 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 26 May 2022 | Purchase | 10,642 | 14.2106 | 151,229 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 27 May 2022 | Purchase | 26,353 | 14.7828 | 389,571 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 26 May 2022 | Purchase | 90,372 | 14.2106 | 1,284,240 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 27 May 2022 | Purchase | 35,793 | 14.7828 | 529,121 | D |
31 May 2022 19:50 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 26 May 2022 | Purchase | 123,043 | 14.2106 | 1,748,515 | D |
24 May 2022 20:09 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 20 May 2022 | Purchase | 37 | 13.9994 | 518 | D |
24 May 2022 20:09 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 20 May 2022 | Purchase | 4,180 | 13.9994 | 58,517 | D |
24 May 2022 20:09 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 20 May 2022 | Purchase | 5,883 | 13.9994 | 82,358 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)